Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
Status:
Completed
Trial end date:
1986-06-01
Target enrollment:
Participant gender:
Summary
To evaluate whether hepatitis B immune globulin with a high level of antibody against the
hepatitis B antigen would be capable of interrupting maternal-fetal transmission of hepatitis
B virus, the single most important route of hepatitis spread in the entire Third World.